Call for Abstract

17th International Conference on Alzheimers Disease & Dementia, will be organized around the theme “”

Dementia-2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Dementia-2023

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Neurology is the branch of medicine that deals with nervous system problems, which include both the central and peripheral nervous systems. The nervous system is a sophisticated and practical system that regulates and coordinates body actions. It is divided into two parts: the central nervous system and the peripheral nervous system, which include their coverings, blood vessels, and all effector tissue, such as muscle. A neurologist is a doctor who has specialized in neurology. Neurologists specialize in problems of the brain, spinal cord, and nerves.

Dementia is a term used to describe the symptoms of a variety of brain diseases. Alzheimer's disease is the most commonly recognized disorder, but other possibilities include brain disease. Early diagnosis aids in therapy, support, and design. Medications could help with some of the symptoms of insanity, but there is no permanent cure. The illness isn't typical for all elderly folks, as the majority of persons with insanity square measure older than 65. The prevalence of insanity rises with age, but it is not impossible for an elderly person to develop it. However, only one in every four patients with Alzheimer's disease or insanity has been diagnosed.

Alzheimer's disease is the most prevalent cause of dementia in older persons, and it usually begins slowly and worsens with time. The most common early sign is trouble recalling recent events, sometimes known as short-term memory loss. By the end stage of Alzheimer's, the damage has spread and brain tissue has decreased significantly. Language problems, mood changes, loss of motivation, poorly managing self-care, and behavioural concerns can all occur as the condition progresses. Body functions deteriorate over time, eventually causing death.

Numerous bodily functions, including balance, mobility, speech, respiration, and heart function, are impacted by neurodegenerative diseases.  Many of these disorders are hereditary. Sometimes the cause is a medical problem such as alcoholism, a tumour, or a stroke. Toxins, chemicals, and viruses are possible culprits as well. Neurodegenerative diseases can be life-threatening. It all depends on the type. Most of them are incurable. Treatments may help alleviate symptoms, decrease discomfort, and boost mobility.

  • Track 4-1Amyotrophic lateral sclerosis
  • Track 4-2Lewy body disease
  • Track 4-3Parkinsons disease

Lewy bodies are protein deposits that form in nerve cells in areas of the brain important in thinking, memory, and movement. The steady deterioration in mental ability caused by Lewy body dementia. Visual hallucinations and impairments in alertness and concentration are possible symptoms of Lewy body dementia. Parkinson's disease symptoms and side effects, for example, rigid muscles, slow development, and tremors, are among the various repercussions.

  • Track 5-1Neurotransmitter abnormalities
  • Track 5-2Advances in lewy body dementia research

Although some normal age-related changes in memory and thinking occur, disorientation and memory loss that interferes with daily life are not part of the normal aging process. Other signs of brain aging and dementia include the inability to complete tasks independently, difficulty naming items or close family members, forgetting the function of items, repeating questions, taking much longer to complete routine tasks, frequently misplacing items, inability to retrace steps, and becoming disoriented

  • Track 6-1Granulovacuolar Degeneration
  • Track 6-2Neuro-anatomical changes in Ageing
  • Track 6-3Changes in Cerebral Cortical microvasculature

Vascular dementia is the second most common form of dementia after Alzheimer's disease. After Alzheimer's disease, vascular dementia is the most frequent type of dementia. It occurs when reduced blood flow affects brain tissue. Blood flow to brain tissue can be decreased or entirely blocked by a blood clot. Vascular dementia symptoms may appear gradually or after a stroke or significant surgery, such as heart bypass surgery or abdominal surgery.

Psychological well-being issues such as depression, anxiety, PTSD, and stress frequently lead to substance abuse, and using these drugs frequently devastates emotional well-being. When mental illness and substance abuse coexist, the condition is known as Dual Diagnosis or Co-Occurring Disorder. The following are the emotional well-being difficulties that are common with enslavement. Nervousness, Attention Deficit Hyperactivity Disorder, Post-Traumatic Stress Disorder, Eating Disorder, Bipolar Disorder, Schizophrenia, and Personality Disorders.

  • Track 8-1Alcohol addiction
  • Track 8-2Opioid dependence
  • Track 8-3Drug use and toxicity

Child and adolescent psychiatry is concerned with the diagnosis, treatment, and prevention of mental problems in both children and adults. The interdisciplinary channel disorder of emotion and behavior in child and adolescent psychiatry has its basis in neurophysiology, genetics, and environmental factors that affect the child's growth and development. Anxiety disorders, depression, and attention deficit hyperactivity disorder (ADHD) are the most frequent pediatric mental problems. Typically, children with mental disorders have worse educational achievement and high involvement in the criminal justice system. Several effective medications, educational or occupational interventions, as well as specific types of psychotherapy are available for treating child's mental disorders/mental illnesses. Each year, nearly one-fourth of children and teenagers experience some form of mental disorder.

Psychiatry is a clinical specialty that diagnoses and treats intellectual problems, which are usually the ones that require treatment. Psyсhiаtrists аrе experienced сliniсаl mediсаl dосtоrs, they саn Ñ€rеsсribе mediсаtiоns, and they spend a lot of time with patients on mediсine control as а rоutinе оf trеаtmеnt. Begin by identifying the most common mental illnesses and how they differ from normalcy. syсhоlоgy is the study of behaviour and thoughts, including all aspects of awareness and sub-conscientious enjoyment as well as ideas.Psychologists focus intensely on psychotherapy and use behavioural interventions to treat patients who are experiencing emotional and mental distress.

  • Track 10-1Addiction Medicine
  • Track 10-2Clinical Neurophysiology
  • Track 10-3Biological Psychiatry

Neuroimaging biomarkers enable for an early diagnosis of Alzheimer's disease in the preclinical phases. Biomarker changes in patients with late-onset Alzheimer's disease, including results from investigations utilising MRI, advanced MRI techniques, positron emission tomography with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers, and CSF protein levels. Since neuroimaging biomarkers for neurological illnesses are difficult to detect, improved technology is allowing researchers to assess brain health for earlier diagnosis, faster medication development, and more effective therapies.

Dementia is defined as a progressive, irreversible decline in noesis that has an impact on a patient's pre-existing level of functioning. Alzheimer's disease is the most common etiology of the clinical condition of dementedness. Drug development in Alzheimer's disease is based on a growing pathophysiological hypothesis. Approaches to disease modification include the targeting of amyloid process, alphabetic character aggregation, endocrine signal, neuro-inflammation, and neurochemical pathology, with attempts to date yielding abandoned hopes and current promise. The amyloid cascade is crucial to various emerging pharmacological therapies, reflecting its dominance on the pathophysiological stage.

Persons with dementia have multiple psychological feature deficits, which include every memory impairment, which affects the flexibility to seek out new data or recall data previously learned, and one or more of the following symptoms-aphasia, apraxia, agnosia, or government dysfunction-such that the psychological feature deficits have a negative impact on social or activity functioning with a significant decline in previous abilities. As a result, creating caregiving methods for persons with dementia is critical, given the increasing frequency and the concomitant burden that dementia places not just on people, but also on carers, relatives, and the health-care system's resources. Standard perceptions of geriatric nursing offer a picture of care that is slower paced and less difficult than acute care. However, caring for the elderly, particularly those with dementia can be tough, unexpected, and unstable at times. This session covers medical professional education and coaching, care and quality of life, person-centered care, and psychological feature coaching, support and coaching for casual and skilled careers, putting knowledge domain into practise, non-pharmacological interventions, practical foods, and art, music, and life style.

Alzheimer's disease is a progressive dementia characterised by neuron loss and the presence of two major microscopic neuropathological hallmarks: living thing amyloid plaques and living thing neurofibrillary tangles. Early-onset Alzheimer's disease, a rare family form, is caused by a mutation in one of three genes: (amyloid precursor protein), (presenilin 2), or (presenilin 1). Noncontinuous type occurs most commonly after the age of sixty-five and accounts for many occurrences; it may be caused by a combination of hereditary and environmental factors. Amyloid plaques are mostly composed of the toxin amide amyloid which is broken sequentially from a larger precursor super molecule by two enzymes: -secretase (also known as BACE1) and -secretase.

Traumatic brain injury is a problem with numerous origins, pathologies, and tremendously variable and frequently multidimensional clinical manifestations. Because of its affinity for brain systems underlying cognitive and complex behavioural activities, it may induce chronic and severe psychiatric disorder that requires specialist management. Traumatic brain injury is common in various neuropsychiatric illnesses and may act as a breeding ground for novel ideas in neurodegenerative 

The study of neuropharmacology focuses on how drugs change the way the nervous system works and the neural pathways in the brain that are involved in behaviour. Neuropharmacology is divided into two primary subfields: behavioural and molecular. Neuropsychopharmacology, which includes the study of how drug addiction and dependence affect the human brain, is the area of study that behavioural neuropharmacology primarily focuses on. The main objective of molecular neuropharmacology is to create medications that improve brain function by investigating neurons and their neurochemical connections.

Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies are some of the disorders being studied. Dementia, as a generic word, refers to a variety of symptoms that impair memory, everyday functioning, and communication abilities. Alzheimer's disease progresses over time and affects memory and thinking.

  • Track 17-1Primary mental health care and nursing
  • Track 17-2Psychopharmacological treatment
  • Track 17-3Advanced drugs for dementia
  • Track 17-4Family therapy in nursing
  • Track 17-5Cognitive behavioral therapy

Alzheimer's disease is a progressive neurodegenerative disease characterised histopathologically by the presence of plaques made primarily of Abeta amyloid and tangles composed primarily of hyperphosphorylated alphabetic character. There is currently no medication that would reverse the sickness, and everyone in this medical specialty is focused on treating the symptoms of the illness. With numerous new drugs beginning clinical trials, Alzheimer's treatment is entering a fresh new and exciting phase. Several of these new medicines are based on our most recent understanding of the pathologic process of Alzheimer's and are intended to either reduce or stop the disease's progression. Therapies aimed at some aspect of beta-amyloid accumulation, neurofibrillary tangle creation, and the inflammatory response are all being considered, as are the difficulties associated with each space. It's still unclear whether any of those approaches are unbeatable, but the great amount of work in each of those three domains gives some hope that a successful Alzheimer's treatment is on the horizon.

  • Track 18-1Neuroendocrine Pharmacology
  • Track 18-2Neurotransmitter-based targets
  • Track 18-3Deep brain stimulation
  • Track 18-4Super molecule aggregation
  • Track 18-5Neurotrophic factors